Table 1.
Preoperative and intraoperative patient data.
| Patient | Age | Sex | BMI | Date of primary surgery | Side | Primary implants | Prior revisions | Symptoms | Preoperative labs/aspiration | Date of cementless revision surgery | Intraoperative findings | Revision implants |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 72 | Male | 26.7 | 6/2006 | Right | Stryker Triathlon | 8/2006: Revision to Depuy PFC Sigma PS 3/2009: Liner exchange |
Pain, chronic effusions, instability | ESR: 1 CRP: 2.9 Cell count: 420 PMN: 24% |
7/2014 | None | Biomet Vanguard custom titanium alloy, hydroxyapatite coated, plasma sprayed |
| 2 | 69 | Female | 39.5 | 12/2017 | Right | Aesculap Vega PS | None | Pain, chronic effusions, arthrofibrosis | ESR: 13 CRP: 8.39a Cell count: 422 PMN: 57% |
5/2019 | Femoral component loosening | Biomet Vanguard custom titanium alloy, porous coated, ion bombarded |
| 3 | 71 | Male | 32 | 4/2009 | Left | Biomet Vanguard PS | 5/2010: Liner exchange | Pain, chronic effusions, arthrofibrosis | ESR: 5 CRP: 2.9 Cell count: 33 PMN: 20% |
7/2011 | None | Depuy PFC Sigma TC3 custom porous coated |
| 4 | 59 | Female | 26.3 | 11/2009 | Left | Stryker Triathlon PS | None | Pain, chronic effusions | ESR: 4 CRP: 2.9 Cell count: 1031 PMN: 65% |
4/2012 | Instability | Biomet Vanguard custom titanium alloy, porous coated, plasma sprayed |
| 5 | 68 | Male | 26.2 | 10/2001 | Right | Depuy PFC Sigma PS | 2/2012: Liner exchange 11/2013: Revision to Depuy PFC Sigma |
Pain, chronic effusions, instability | ESR: 4 CRP: 2.9 Cell count: 436 PMN: 47% |
11/2019 | Femoral component loosening | Biomet Vanguard custom titanium alloy, porous coated, ion bombarded |
| 6 | 71 | Female | 32 | 7/2012 | Left | Smith & Nephew Legion CR (Oxinium) | None | Pain, instability | ESR: 5 CRP: 2.9 Cell count: 240 PMN: 8% |
2/2015 | None | Biomet Vanguard custom titanium alloy, hydroxyapatite coated, ion bombarded |
| 7A | 65 | Male | 24 | 6/2014 | Right | Depuy Attune PS | None | Pain, arthrofibrosis | ESR: 2 CRP: 2.9 Cell count: 477 PMN: 19% |
9/2018 | None | Biomet Vanguard custom titanium alloy, porous coated, ion bombarded |
| 7B | 65 | Male | 24 | 9/2014 | Left | Depuy Attune PS | None | Pain, arthrofibrosis | ESR: 2 CRP: 2.9 Cell count: 268 PMN: 13% |
10/2019 | Patellar component loosening, instability | Biomet Vanguard custom titanium alloy, porous coated, ion bombarded |
BMI, body mass index; CRP, C-reactive protein; PMN, polymorphonuclear; ESR, erythrocyte sedimentation rate; ROM, range of motion.
Elevated value.